What drives someone to dedicate their career to reimagining medicine? Three women at Novartis share their deeply personal and unique stories.

New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.

Novartis researchers are using data to accelerate drug development.

Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

After being diagnosed with advanced prostate cancer, Van Lacour received a Novartis radioligand therapy as part of a managed access program in 2021. Today, he is living a fulfilling life in his hometown of Natchez, Louisiana, US.

Cardiovascular disease is the leading cause of death in the US, claiming one in four lives. Social factors such as living conditions, education and diet play a key role in determining a person’s heart health, which means cardiovascular disease typically hits vulnerable communities the hardest. Our three-year Closing the Gap initiative with the Jefferson Collaborative for Health Equity (established by Jefferson Health and Thomas Jefferson University) focuses on addressing the upstream social determinants of heart health in five vulnerable neighborhoods in Philadelphia with high rates of stroke and adverse outcomes related to heart disease.

After 40 years of working in information technology, Jim Barrington took a partial retirement from his job as Novartis’ chief information officer and started looking for new ways to apply his skills.